Apogee Therapeutics Inc (APGE)

Apr 03, 2026

Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus

Apr 03, 2026

Apr 03, 2026

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics (APGE) CMO sells shares worth $466,619 - Investing.com India

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics (APGE) CMO trades 5,500 shares under 10b5-1 plan - Stock Titan

Apr 03, 2026

Apr 03, 2026

Responsive Playbooks and the APGE Inflection - Stock Traders Daily

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN

Apr 03, 2026

Apr 03, 2026

APGE Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 03, 2026

Mizuho Initiates Coverage of Apogee Therapeutics (APGE) with Outperform Recommendation - MSN

Apr 03, 2026

Apr 03, 2026

Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE - MarketBeat

Apr 03, 2026

Apr 02, 2026

Apogee Therapeutics CMO sells $361,860 in shares - Investing.com

Apr 02, 2026

Apr 02, 2026

Deutsche Bank Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $118 - Moomoo

Apr 02, 2026

Apr 02, 2026

SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat

Apr 02, 2026

Apr 01, 2026

Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus

Apr 01, 2026

Apr 01, 2026

Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week HighHere's What Happened - MarketBeat

Apr 01, 2026

Mar 31, 2026

Apogee Therapeutics prices upsized $350M offering at $70 a share - MSN

Mar 31, 2026

Mar 31, 2026

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $137 - Moomoo

Mar 31, 2026

Mar 30, 2026

APGE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 30, 2026

Mar 30, 2026

Market Rankings: Will Apogee Therapeutics Inc benefit from seasonalityEarnings Recap Summary & Weekly Setup with ROI Potential - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Should Apogee Therapeutics’ (APGE) Infrequent-Dosing AD Data and $403M Equity Raise Require Investor Action? - simplywall.st

Mar 30, 2026

Mar 30, 2026

BTIG reiterates Buy on Apogee Therapeutics stock, $137 target By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

BTIG reiterates Buy on Apogee Therapeutics stock, $137 target - Investing.com

Mar 30, 2026

Mar 30, 2026

Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $110.00 at Mizuho - MarketBeat

Mar 30, 2026

Mar 30, 2026

Mizuho raises Apogee Therapeutics stock price target on AD data By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

Mizuho raises Apogee Therapeutics stock price target on AD data - Investing.com

Mar 30, 2026

Mar 30, 2026

Mizuho Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $110 - Moomoo

Mar 30, 2026

Mar 29, 2026

Apogee Therapeutics announces $300 million public offering - MSN

Mar 29, 2026

Mar 28, 2026

APGE SEC FilingsApogee Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 28, 2026

Mar 28, 2026

Apogee Therapeutics (APGE) price target increased by 11.74% to 118.86 - MSN

Mar 28, 2026

Mar 27, 2026

Wolfe Research initiates coverage of Apogee Therapeutics (APGE) with peer perform recommendation - MSN

Mar 27, 2026

Mar 27, 2026

Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus

Mar 27, 2026

Mar 27, 2026

Apogee Therapeutics CFO Henderson sells $170k in stock By Investing.com - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

Apogee Therapeutics CFO Henderson sells $170k in stock - Investing.com

Mar 27, 2026

Mar 27, 2026

Apogee Therapeutics (APGE) Is Up 17.8% After $403 Million Follow-On Tied To Zumilokibart Data - finance.yahoo.com

Mar 27, 2026

Mar 27, 2026

Apogee Therapeutics (APGE) CFO sells 2,000 shares in planned trade - Stock Titan

Mar 27, 2026

Mar 27, 2026

Fairmount Funds reveals near-10% Apogee Therapeutics (APGE) stake and 60-day lock-up - Stock Titan

Mar 27, 2026

Mar 27, 2026

Apogee Therapeutics raises $403 million in stock offering By Investing.com - Investing.com Australia

Mar 27, 2026

Mar 26, 2026

APGE stock up as skin disease drug shows sustained 52-week efficacy - MSN

Mar 26, 2026

Mar 26, 2026

Apogee Therapeutics raises $403 million in stock offering - Investing.com

Mar 26, 2026

Mar 26, 2026

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million - The Manila Times

Mar 26, 2026

Mar 26, 2026

Vanguard disaggregates holdings; Apogee Therapeutics (NASDAQ: APGE) shows 0 shares - Stock Titan

Mar 26, 2026

Mar 26, 2026

Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's What Really Matters for Investors - The Motley Fool

Mar 26, 2026

Mar 26, 2026

Apogee Therapeutics stock hits all-time high at 84.56 USD By Investing.com - Investing.com Australia

Mar 26, 2026

Mar 26, 2026

Apogee Therapeutics Prices Upsized Public Equity Offering - TipRanks

Mar 26, 2026